Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: A case report

K. Tanaka, T. Honna, Y. Kitano, Tatsuo Kuroda, K. Tanaka, N. Morikawa, H. Matsuda, N. Kawashima, K. Matsuoka, J. Miyauchi

研究成果: Article

16 引用 (Scopus)

抄録

Fibrolamellar carcinoma (FLC), a variant of hepatocellular carcinoma (HCC), very rarely occurs in association with cholangiocarcinoma (CC). This report describes the first case of FLC coexisting with CC (FLC-CC) from Japan. Although the major part of the tumour located in the right lobe of the liver showed the typical features of FLC, CC was admixed with the FLC, not only in the primary hepatic tumour, but also in the lymph node metastases. Immunohistochemical analysis revealed that, although carcinoembryonic antigen (CEA), which can be detected with monoclonal antibodies in the cytoplasm and the cell surface of CC cells but not HCC cells, was expressed in only the CC cells in the primary tumour, it was expressed extensively in the cytoplasm of both CC and FLC cells in the metastatic and recurrent tumours. Furthermore, Hep Par 1, a hepatocyte specific antigen, was also expressed in both the FLC and CC cells. These findings suggest that, in this case, both FLC and CC were possibly derived from the same cancer stem cell with the capacity to differentiate into both hepatocytes and bile duct epithelium, and that both the cellular components, therefore, exhibited biphenotypic antigen expression.

元の言語English
ページ(範囲)884-887
ページ数4
ジャーナルJournal of Clinical Pathology
58
発行部数8
DOI
出版物ステータスPublished - 2005 8
外部発表Yes

Fingerprint

Cholangiocarcinoma
Carcinoma
Antigens
Hepatocytes
Hepatocellular Carcinoma
Neoplasms
Cytoplasm
Neoplastic Stem Cells
Liver
Carcinoembryonic Antigen
Bile Ducts
Japan
Epithelium
Lymph Nodes
Monoclonal Antibodies
Neoplasm Metastasis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

これを引用

Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression : A case report. / Tanaka, K.; Honna, T.; Kitano, Y.; Kuroda, Tatsuo; Tanaka, K.; Morikawa, N.; Matsuda, H.; Kawashima, N.; Matsuoka, K.; Miyauchi, J.

:: Journal of Clinical Pathology, 巻 58, 番号 8, 08.2005, p. 884-887.

研究成果: Article

Tanaka, K, Honna, T, Kitano, Y, Kuroda, T, Tanaka, K, Morikawa, N, Matsuda, H, Kawashima, N, Matsuoka, K & Miyauchi, J 2005, 'Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: A case report', Journal of Clinical Pathology, 巻. 58, 番号 8, pp. 884-887. https://doi.org/10.1136/jcp.2004.021956
Tanaka, K. ; Honna, T. ; Kitano, Y. ; Kuroda, Tatsuo ; Tanaka, K. ; Morikawa, N. ; Matsuda, H. ; Kawashima, N. ; Matsuoka, K. ; Miyauchi, J. / Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression : A case report. :: Journal of Clinical Pathology. 2005 ; 巻 58, 番号 8. pp. 884-887.
@article{0df1d2d65e614752bf244ed0eca2048d,
title = "Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: A case report",
abstract = "Fibrolamellar carcinoma (FLC), a variant of hepatocellular carcinoma (HCC), very rarely occurs in association with cholangiocarcinoma (CC). This report describes the first case of FLC coexisting with CC (FLC-CC) from Japan. Although the major part of the tumour located in the right lobe of the liver showed the typical features of FLC, CC was admixed with the FLC, not only in the primary hepatic tumour, but also in the lymph node metastases. Immunohistochemical analysis revealed that, although carcinoembryonic antigen (CEA), which can be detected with monoclonal antibodies in the cytoplasm and the cell surface of CC cells but not HCC cells, was expressed in only the CC cells in the primary tumour, it was expressed extensively in the cytoplasm of both CC and FLC cells in the metastatic and recurrent tumours. Furthermore, Hep Par 1, a hepatocyte specific antigen, was also expressed in both the FLC and CC cells. These findings suggest that, in this case, both FLC and CC were possibly derived from the same cancer stem cell with the capacity to differentiate into both hepatocytes and bile duct epithelium, and that both the cellular components, therefore, exhibited biphenotypic antigen expression.",
author = "K. Tanaka and T. Honna and Y. Kitano and Tatsuo Kuroda and K. Tanaka and N. Morikawa and H. Matsuda and N. Kawashima and K. Matsuoka and J. Miyauchi",
year = "2005",
month = "8",
doi = "10.1136/jcp.2004.021956",
language = "English",
volume = "58",
pages = "884--887",
journal = "Journal of Clinical Pathology - Clinical Molecular Pathology",
issn = "0021-9746",
publisher = "BMJ Publishing Group",
number = "8",

}

TY - JOUR

T1 - Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression

T2 - A case report

AU - Tanaka, K.

AU - Honna, T.

AU - Kitano, Y.

AU - Kuroda, Tatsuo

AU - Tanaka, K.

AU - Morikawa, N.

AU - Matsuda, H.

AU - Kawashima, N.

AU - Matsuoka, K.

AU - Miyauchi, J.

PY - 2005/8

Y1 - 2005/8

N2 - Fibrolamellar carcinoma (FLC), a variant of hepatocellular carcinoma (HCC), very rarely occurs in association with cholangiocarcinoma (CC). This report describes the first case of FLC coexisting with CC (FLC-CC) from Japan. Although the major part of the tumour located in the right lobe of the liver showed the typical features of FLC, CC was admixed with the FLC, not only in the primary hepatic tumour, but also in the lymph node metastases. Immunohistochemical analysis revealed that, although carcinoembryonic antigen (CEA), which can be detected with monoclonal antibodies in the cytoplasm and the cell surface of CC cells but not HCC cells, was expressed in only the CC cells in the primary tumour, it was expressed extensively in the cytoplasm of both CC and FLC cells in the metastatic and recurrent tumours. Furthermore, Hep Par 1, a hepatocyte specific antigen, was also expressed in both the FLC and CC cells. These findings suggest that, in this case, both FLC and CC were possibly derived from the same cancer stem cell with the capacity to differentiate into both hepatocytes and bile duct epithelium, and that both the cellular components, therefore, exhibited biphenotypic antigen expression.

AB - Fibrolamellar carcinoma (FLC), a variant of hepatocellular carcinoma (HCC), very rarely occurs in association with cholangiocarcinoma (CC). This report describes the first case of FLC coexisting with CC (FLC-CC) from Japan. Although the major part of the tumour located in the right lobe of the liver showed the typical features of FLC, CC was admixed with the FLC, not only in the primary hepatic tumour, but also in the lymph node metastases. Immunohistochemical analysis revealed that, although carcinoembryonic antigen (CEA), which can be detected with monoclonal antibodies in the cytoplasm and the cell surface of CC cells but not HCC cells, was expressed in only the CC cells in the primary tumour, it was expressed extensively in the cytoplasm of both CC and FLC cells in the metastatic and recurrent tumours. Furthermore, Hep Par 1, a hepatocyte specific antigen, was also expressed in both the FLC and CC cells. These findings suggest that, in this case, both FLC and CC were possibly derived from the same cancer stem cell with the capacity to differentiate into both hepatocytes and bile duct epithelium, and that both the cellular components, therefore, exhibited biphenotypic antigen expression.

UR - http://www.scopus.com/inward/record.url?scp=23444444701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23444444701&partnerID=8YFLogxK

U2 - 10.1136/jcp.2004.021956

DO - 10.1136/jcp.2004.021956

M3 - Article

C2 - 16049296

AN - SCOPUS:23444444701

VL - 58

SP - 884

EP - 887

JO - Journal of Clinical Pathology - Clinical Molecular Pathology

JF - Journal of Clinical Pathology - Clinical Molecular Pathology

SN - 0021-9746

IS - 8

ER -